XILINX INC (XLNX) Stock Fundamental Analysis

NASDAQ:XLNX

194.92
-21.63 (-9.99%)
At close: Feb 11, 2022
193.05
-1.87 (-0.96%)
After Hours: 2/11/2022, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XLNX. XLNX was compared to 113 industry peers in the Semiconductors & Semiconductor Equipment industry. XLNX has a bad profitability rating. Also its financial health evaluation is rather negative. XLNX is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year XLNX was profitable.
XLNX Yearly Net Income VS EBIT VS OCF VS FCFXLNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B

1.2 Ratios

Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XLNX Yearly ROA, ROE, ROICXLNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 10 20 30

1.3 Margins

Industry RankSector Rank
OM 26.39%
PM (TTM) 25.26%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XLNX Yearly Profit, Operating, Gross MarginsXLNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, XLNX has more shares outstanding
  • Compared to 1 year ago, XLNX has a worse debt to assets ratio.
XLNX Yearly Shares OutstandingXLNX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M
XLNX Yearly Total Debt VS Total AssetsXLNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B 5B

2.2 Solvency

  • XLNX has an Altman-Z score of 13.19. This indicates that XLNX is financially healthy and has little risk of bankruptcy at the moment.
  • A Debt/Equity ratio of 0.41 indicates that XLNX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Altman-Z 13.19
ROIC/WACCN/A
WACCN/A
XLNX Yearly LT Debt VS Equity VS FCFXLNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • XLNX has a Current Ratio of 6.62. This indicates that XLNX is financially healthy and has no problem in meeting its short term obligations.
  • A Quick Ratio of 6.13 indicates that XLNX has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 6.62
Quick Ratio 6.13
XLNX Yearly Current Assets VS Current LiabilitesXLNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • XLNX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 45.98%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 4.85% on average over the past years.
  • XLNX shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.43%.
  • The Revenue has been growing slightly by 7.29% on average over the past years.
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%

3.2 Future

  • XLNX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.30% yearly.
  • The Revenue is expected to grow by 11.09% on average over the next years. This is quite good.
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XLNX Yearly Revenue VS EstimatesXLNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B 5B
XLNX Yearly EPS VS EstimatesXLNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 51.16, XLNX can be considered very expensive at the moment.
  • When comparing the Price/Earnings ratio of XLNX to the average of the S&P500 Index (26.68), we can say XLNX is valued expensively.
  • XLNX is valuated quite expensively with a Price/Forward Earnings ratio of 44.12.
  • When comparing the Price/Forward Earnings ratio of XLNX to the average of the S&P500 Index (28.06), we can say XLNX is valued expensively.
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
XLNX Price Earnings VS Forward Price EarningsXLNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 39.69
XLNX Per share dataXLNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as XLNX's earnings are expected to grow with 25.35% in the coming years.
PEG (NY)0.89
PEG (5Y)10.56
EPS Next 2Y30.1%
EPS Next 3Y25.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. Dividend

5.1 Amount

  • XLNX has a yearly dividend return of 0.76%, which is pretty low.
  • Compared to an average S&P500 Dividend Yield of 1.84, XLNX's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.76%

5.2 History

  • The dividend of XLNX has a limited annual growth rate of 2.55%.
  • XLNX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.55%
Div Incr YearsN/A
Div Non Decr YearsN/A
XLNX Yearly Dividends per shareXLNX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

  • XLNX pays out 9.87% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of XLNX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP9.87%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
XLNX Yearly Income VS Free CF VS DividendXLNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M 1B
XLNX Dividend Payout.XLNX Dividend Payout, showing the Payout Ratio.XLNX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

XILINX INC

NASDAQ:XLNX (2/11/2022, 8:00:02 PM)

After market: 193.05 -1.87 (-0.96%)

194.92

-21.63 (-9.99%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A
Earnings (Next)02-08
Inst Owners0%
Inst Owner Change0%
Ins Owners0.17%
Ins Owner Change0%
Market Cap48.41B
Revenue(TTM)3.68B
Net Income(TTM)928.85M
Analysts67.2
Price Target192.41 (-1.29%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.76%
Yearly Dividend1.51
Dividend Growth(5Y)2.55%
DP9.87%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 51.16
Fwd PE 44.12
P/S 13.17
P/FCF N/A
P/OCF N/A
P/B 13.18
P/tB N/A
EV/EBITDA 39.69
EPS(TTM)3.81
EY1.95%
EPS(NY)4.42
Fwd EY2.27%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS14.8
BVpS14.79
TBVpSN/A
PEG (NY)0.89
PEG (5Y)10.56
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.64%
ROE 25.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 26.39%
PM (TTM) 25.26%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.62
Quick Ratio 6.13
Altman-Z 13.19
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.98%
EPS 3Y-2.2%
EPS 5Y4.85%
EPS Q2Q%86.96%
EPS Next Y57.65%
EPS Next 2Y30.1%
EPS Next 3Y25.35%
EPS Next 5Y19.3%
Revenue 1Y (TTM)20.43%
Revenue growth 3Y8.46%
Revenue growth 5Y7.29%
Sales Q2Q%25.85%
Revenue Next Year23.37%
Revenue Next 2Y16.28%
Revenue Next 3Y13.42%
Revenue Next 5Y11.09%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

XILINX INC / XLNX FAQ

What is the fundamental rating for XLNX stock?

ChartMill assigns a fundamental rating of 7 / 10 to XLNX.


Can you provide the valuation status for XILINX INC?

ChartMill assigns a valuation rating of 2 / 10 to XILINX INC (XLNX). This can be considered as Overvalued.


Can you provide the profitability details for XILINX INC?

XILINX INC (XLNX) has a profitability rating of 7 / 10.


What is the expected EPS growth for XILINX INC (XLNX) stock?

The Earnings per Share (EPS) of XILINX INC (XLNX) is expected to grow by 57.65% in the next year.


Can you provide the dividend sustainability for XLNX stock?

The dividend rating of XILINX INC (XLNX) is 5 / 10 and the dividend payout ratio is 9.87%.